Print

Yamanouchi Pharmaceutical Co., Ltd. Terminates Marketing Agreement With Daiichi Suntory Pharma Co., Ltd. 
10/19/2005 5:12:46 PM

Tokyo (JCNN) - Yamanouchi Pharmaceutical Co., Ltd. (TSE: 4503) has announced that is has agreed with Daiichi Suntory Pharma Co., Ltd. (TSE:) to terminate a marketing agreement between the two companies regarding the penem-type antibiotic Farom (faropenem sodium) on March 31, 2005.